John S. McBride

2017

In 2017, John S. McBride earned a total compensation of $647.3K as Former Chief Operating Officer and Chief Financial Officer at Tokai Pharmaceuticals, a 59% increase compared to previous year.

Compensation breakdown

Option Awards$73,405
Salary$169,918
Other$403,955
Total$647,278

McBride received $404K in other compensation, accounting for 62% of the total pay in 2017.

McBride also received $73.4K in option awards and $169.9K in salary.

Rankings

In 2017, John S. McBride's compensation ranked 10,923rd out of 14,666 executives tracked by ExecPay. In other words, McBride earned more than 25.5% of executives.

ClassificationRankingPercentile
All
10,923
out of 14,666
26th
Division
Manufacturing
4,259
out of 5,770
26th
Major group
Chemicals And Allied Products
1,529
out of 2,074
26th
Industry group
Drugs
1,252
out of 1,730
28th
Industry
Pharmaceutical Preparations
973
out of 1,329
27th
Source: SEC filing on April 30, 2018.

McBride's colleagues

We found five more compensation records of executives who worked with John S. McBride at Tokai Pharmaceuticals in 2017.

2017

Gregory Flesher

Tokai Pharmaceuticals

Chief Executive Officer

2017

Jodie Morrison

Tokai Pharmaceuticals

Chief Executive Officer

2017

Catherine Turkel

Tokai Pharmaceuticals

President

2017

Christine Ocampo

Tokai Pharmaceuticals

Chief Financial Officer

2017

Jon Kuwahara

Tokai Pharmaceuticals

Senior Vice President of Finance and Administration

You may also like